Data month 2026-08
METiS Therapeutics Inc.metistx.comUses AI and machine learning for small-molecule, nucleic-acid, and biologic delivery R&D.
According to AlphaMoat, in 2026-08 METiS Therapeutics (metistx.com) received 3,507 monthly visits (+13.1% MoM) — ranked #13,496 of 17,407 AI websites with traffic data, and #2,315 of 3,173 in Industry Services; its largest market is United States (100.0% of visits).
Monthly Visits · 2026-08
3.5K+13.1%
Overall Rank (17,407)
#13,496
Industry Services Rank (3,173)
#2,315
Top Market
United States100.0%
What is METiS Therapeutics
Product Overview
METiS Therapeutics uses artificial intelligence, machine learning, and molecular dynamics to develop delivery systems for small-molecule, biologic, and advanced nucleic-acid therapies, and combines AI with high-throughput in vivo screening to discover novel lipid nanoparticles.
Key Features2 items
- 01Its delivery engine has produced LNPs that target multiple organ systems, showing high delivery efficiency and clean safety profiles in mouse and non-human-primate experiments
- 02the company also opens collaborations around nanoparticles developed with AI and machine learning
12-Month Traffic Trend
Hover for monthly values
Latest 3.5KMoM+13.1%
2026-06
2.8K
—
2026-07
3.1K
+10.6%
2026-08
3.5K
+13.1%
Visits by Country · Top 5
2026-08 · Share of total visits
United States
3,507100.0%
Popular in Industry Services
Click for details, or "+ Compare" to compare with METiS Therapeutics
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.